false
0002019505
0002019505
2025-08-15
2025-08-15
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934
August 15, 2025
Date of Report (Date of earliest event reported)
Health In Tech, Inc.
(Exact name of registrant as specified in its charter)
| Nevada |
|
001-42449 |
|
87-3545722 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
|
701 S. Colorado Ave, Suite 1
Stuart, FL |
|
34994 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (888) 373-0333
N/A
(Former name or former address, if changed since
last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Class
A Common Stock, $0.001 par value per share |
|
HIT |
|
The
Nasdaq Stock Market LLC
(Nasdaq
Capital Market) |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 15, 2025, the Compensation
Committee of the Board of Directors of Health In Tech, Inc., a Nevada corporation (the “Company”), approved the grant of
restricted stock awards (the “RSAs”) to Tim Johnson, the Company’s Chief Executive Officer, Linlin (Julia) Qian, the
Company’s Chief Financial Officer, and (Mo) Imran Yousuf, the Company’s Chief Technology Officer. The Company granted the
RSAs to Mr. Johnson, Ms. Qian and Mr. Yousef in connection with services these named executive officers are providing to the Company
to develop two new programs, which are referred to in this Current Report on Form 8-K as “Program 1” and “Program 2”,
and collectively as, the “Programs”. Mr. Johnson received a grant of 17,000 shares of restricted stock in connection with
Program 1 and 17,000 shares of restricted stock in connection with Program 2. Ms. Qian received a grant of 10,000 shares of restricted
stock in connection with Program 1 and 17,000 shares of restricted stock in connection with Program 2. Mr. Yousuf received a grant of
3,500 shares of restricted stock in connection with Program 1 and 3,500 shares of restricted stock in connection with Program 2. Fifty
percent (50%) of the total number of shares of restricted stock granted to each recipient shall vest in equal monthly installments over
a twelve (12) month period commencing on the date that the first of the two Programs is successfully launched and fully operational in
the marketplace, and the remaining fifty percent (50%) shall vest in equal monthly installments over a twelve (12) month period commencing
on the date that the other Program is successfully launched and fully operational in the marketplace. The RSAs were granted pursuant
to the Health In Tech, Inc. Equity Incentive Plan and are subject to the terms and conditions set forth in the Restricted Stock Award
Agreements previously approved by the Compensation Committee.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 19, 2025
HEALTH IN TECH, INC.
| By: |
/s/ Tim Johnson |
|
| Name: |
Tim Johnson |
|
| Title: |
Chief Executive Officer |
|
2
